Related Articles
Baseline lymphopenia as prognostic factor in patients with metastatic breast cancer treated with palbociclib
Improved prognosis of low baseline neutrophil‑to‑lymphocyte ratio is significantly exclusive in breast cancer patients with high absolute counts of lymphocytes
Comprehensive prognostic prediction of metastatic breast cancer treated with eribulin using blood‑based parameters and ratio
Clinical predictors of response to single‑agent immune checkpoint inhibitors in chemotherapy‑pretreated non‑small cell lung cancer
Phase II study of subcutaneously administered interleukin-2 in combination with medroxyprogesterone acetate and antioxidant agents as maintenance treatment in advanced cancer responders to previous chemotherapy